Dimebon improves cognitive function in people with mild to moderate Alzheimer's disease

Affiliations

Comment

Serge Gauthier. Evid Based Ment Health. 2009 Feb.

. 2009 Feb;12(1):21.

doi: 10.1136/ebmh.12.1.21.

¹ McGill Center for Studies in Aging, Douglas Mental Health University Institute, Montreal, Canada.

No abstract available

Comment on

Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study.
Doody RS, Gavrilova SI, Sano M, Thomas RG, Aisen PS, Bachurin SO, Seely L, Hung D; dimebon investigators. Doody RS, et al. Lancet. 2008 Jul 19;372(9634):207-15. doi: 10.1016/S0140-6736(08)61074-0. Lancet. 2008. PMID: 18640457 Clinical Trial.